FDA-Drug2026-03-11Class IIPROCESSING DEFECT
New Life Pharma Tirzepatide injection recalled for sterility concerns
What this means
New Life Pharma LLC is recalling one lot of Tirzepatide 15mg injection due to lack of assurance of sterility. The affected lot (240709) was distributed in Ohio. No injuries have been reported.
- Check your medication vial for lot number 240709 and expiration date 7/31/2026
- Do not use this lot; contact your prescriber or pharmacist for a replacement
- If you have already used this medication and have concerns, contact your doctor
The agency's original wording
Hazard
Lack of Assurance of Sterility
Intended for
Adults
Illnesses reported
None reported
Sold states
OH
Affected count
45 vials
Manufactured in
265 Livingston St, N/A, Northvale, NJ, United States
Products
Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0395-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.